ArticleFrontiers in oncology2026

Anlotinib-temozolomide combination achieves durable response in multimodal-resistant primary breast angiosarcoma with skull base metastasis and dural involvement: a case report.

Shujie Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.